Yong Kenneth, Dogra Gursharan, Boudville Neil, Lim Wai
Department of Nephrology, Prince Of Wales Hospital, Sydney, Australia
School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.
Perit Dial Int. 2018 Jan-Feb;38(1):18-23. doi: 10.3747/pdi.2017.00060. Epub 2017 Nov 2.
Large epidemiological studies have demonstrated an early survival advantage with the initiation of peritoneal dialysis (PD) compared to haemodialysis (HD). Chronic inflammation may contribute to atherosclerosis and cardiovascular (CVD) mortality in end-stage kidney disease (ESKD). We hypothesize that the initiation of HD in ESKD patients is associated with a greater inflammatory response compared with PD.
To examine the effects of initiating HD and PD upon inflammation and CVD risk markers in ESKD patients.
We performed a pilot prospective study on 75 predialysis CKD stage-5 subjects comparing the effects of HD and PD upon high sensitivity C-reactive protein (hsCRP), interleukin(IL)-12, IL-18 and pulse wave velocity (PWV). Study visits were conducted 3 - 6 months before (baseline) and after (follow-up) initiation of dialysis RESULTS: Thirty-nine and 36 patients were initiated on HD and PD respectively. HD patients were older than PD patients (65.1 ± 2.1 vs 57.7 ± 2.7 years; = 0.03) but had similar baseline systolic blood pressure (SBP), pulse pressure (PP), hsCRP, IL-12, IL-18, and PWV. At follow-up, HD patients had significantly increased hsCRP levels [5.2(3.7, 7.3) vs 1.7(1.0, 2.8)g/L; < 0.001] compared to PD. Follow-up blood pressure, IL-12, IL-18, and PWV were similar between groups. A significant association remained between hsCRP and HD after adjustment for age, previous CVD, and residual urine output.
The initiation of HD was associated with significantly increased hsCRP compared to PD. Further study is required to determine the plausibility of inflammation as a potential underlying contributor to the observed early mortality difference between dialysis modalities.
大型流行病学研究表明,与血液透析(HD)相比,开始腹膜透析(PD)具有早期生存优势。慢性炎症可能导致终末期肾病(ESKD)患者发生动脉粥样硬化和心血管疾病(CVD)死亡。我们假设,与PD相比,ESKD患者开始HD与更大的炎症反应相关。
研究开始HD和PD对ESKD患者炎症和CVD风险标志物的影响。
我们对75例透析前慢性肾脏病5期患者进行了一项前瞻性试点研究,比较HD和PD对高敏C反应蛋白(hsCRP)、白细胞介素(IL)-12、IL-18和脉搏波速度(PWV)的影响。在开始透析前3 - 6个月(基线)和开始透析后(随访)进行研究访视。结果:分别有39例和36例患者开始HD和PD治疗。HD组患者比PD组患者年龄更大(65.1±2.1岁对57.7±2.7岁;P = 0.03),但基线收缩压(SBP)、脉压(PP)、hsCRP、IL-12、IL-18和PWV相似。随访时,与PD组相比,HD组患者hsCRP水平显著升高[5.2(3.7,7.3)对1.7(1.0,2.8)mg/L;P < 0.001]。两组间随访血压、IL-12、IL-18和PWV相似。在调整年龄、既往CVD和残余尿量后,hsCRP与HD之间仍存在显著关联。
与PD相比,开始HD与hsCRP显著升高相关。需要进一步研究以确定炎症作为透析方式之间观察到的早期死亡率差异的潜在潜在因素的合理性。